{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T17:20:24Z","timestamp":1774718424614,"version":"3.50.1"},"reference-count":94,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"unspecified","delay-in-days":2041,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:p>Over 60,000 Canadians are infected with human immunodeficiency virus (HIV). Greater than 50% of these individuals will develop a neurological disorder despite the availability of highly active antiretroviral therapy. HIV causes nervous system disease at all stages of infection with adverse effects on quality of life, adherence to medications, employment and survival. These disorders include opportunistic infections in addition to distinct HIV-associated neurological syndromes and undesirable treatment-related effects. The latter two groups of disorders are often undiagnosed and untreated in both adolescents and adults. Direct HIV infection of central nervous system causes HIV-associated dementia, which is a progressive subcortical dementia. HIV infection of the peripheral nervous system produces a painful sensory neuropathy termed distal sensory polyneuropathy, which may be exacerbated by several antiretroviral drugs. Other important HIV-induced neurological disorders include vacuolar myelopathy and an increased risk of seizures. Future issues that will confound the presentation and treatment of HIV-induced nervous system disorders include the increasing prevalence of drug-resistant HIV strains, increasing age of HIV-infected patients, hepatitis C virus co-infection and the Immune Reconstitution Inflammatory Syndrome. Herein, we review the clinical presentations, underlying pathogenesis and treatments of this burgeoning group of neurological disorders.<\/jats:p>","DOI":"10.1017\/s0317167100007009","type":"journal-article","created":{"date-parts":[[2014,12,12]],"date-time":"2014-12-12T15:15:30Z","timestamp":1418397330000},"page":"285-295","source":"Crossref","is-referenced-by-count":53,"title":["NeuroAIDS: An Evolving Epidemic"],"prefix":"10.1017","volume":"36","author":[{"given":"Christopher","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysa","family":"Boiss\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Rourke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. John","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"S0317167100007009_manual_ref-46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000008112","article-title":"Assessment of cognitive function in asymptomatic HIV-positive subjects","volume":"42","author":"Grassi","year":"1999","journal-title":"Eur Neurol."},{"key":"S0317167100007009_manual_ref-77","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-004-0529-6"},{"key":"S0317167100007009_manual_ref-76","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMcp022282","article-title":"Clinical practice. Painful sensory neuropathy","volume":"348","author":"Mendell","year":"2003","journal-title":"N Engl J Med."},{"key":"S0317167100007009_manual_ref-29","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/S1355617704102130","article-title":"The impact of HIV-associated neuropsychological impairment on everyday functioning","volume":"10","author":"Heaton","year":"2004","journal-title":"J Int Neuropsychol Soc."},{"key":"S0317167100007009_manual_ref-32","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2005.21.706"},{"key":"S0317167100007009_manual_ref-23","first-page":"229","article-title":"New-onset delusions and hallucinations in patients infected with HIV","volume":"26","author":"Alciati","year":"2001","journal-title":"J Psychiatry Neurosci."},{"key":"S0317167100007009_manual_ref-55","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.pctr.0020013","article-title":"Factors in AIDS dementia complex trial design: results and lessons from the abacavir trial","volume":"2","author":"Brew","year":"2007","journal-title":"PLoS Clin Trials."},{"key":"S0317167100007009_manual_ref-83","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/519285","article-title":"Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV","volume":"196","author":"Letendre","year":"2007","journal-title":"J Infect Dis."},{"key":"S0317167100007009_manual_ref-54","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20198"},{"key":"S0317167100007009_manual_ref-85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/oso\/9780195133639.001.0001","volume-title":"HIV Neurology","author":"Brew","year":"2001"},{"key":"S0317167100007009_manual_ref-4","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000247565.80633.d2"},{"key":"S0317167100007009_manual_ref-74","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1212\/01.wnl.0000203126.01416.77","article-title":"Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study","volume":"66","author":"Herrmann","year":"2006","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ana.410190603","article-title":"The AIDS dementia complex: II","volume":"19","author":"Navia","year":"1986","journal-title":"Neuropathology. Ann Neurol."},{"key":"S0317167100007009_manual_ref-44","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-119-10-199311150-00006"},{"key":"S0317167100007009_manual_ref-88","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/ana.410410406","article-title":"Peripheral neuropathy in human immunodeficiency virus-infected patients with the diffuse infiltrative lymphocytosis syndrome","volume":"41","author":"Moulignier","year":"1997","journal-title":"Ann Neurol."},{"key":"S0317167100007009_manual_ref-60","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","article-title":"Neuroprotective and anti-human immunodeficiency virus activity of minocycline","volume":"293","author":"Zink","year":"2005","journal-title":"JAMA."},{"key":"S0317167100007009_manual_ref-16","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1212\/WNL.53.8.1634","article-title":"Epidermal nerve fiber density and sural nerve morphometry in peripheral neuropathies","volume":"53","author":"Herrmann","year":"1999","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-28","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrn2040","article-title":"HIV and antiretroviral therapy in the brain: neuronal injury and repair","volume":"8","author":"Ellis","year":"2007","journal-title":"Nat Rev Neurosci."},{"key":"S0317167100007009_manual_ref-82","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1128\/JVI.78.18.10133-10148.2004","article-title":"Independent evolution of human immuno-deficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment","volume":"78","author":"Smit","year":"2004","journal-title":"J Virol."},{"key":"S0317167100007009_manual_ref-95","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0140-6736(95)11035-6","article-title":"Neurological complications of HIV infection","volume":"348","author":"Price","year":"1996","journal-title":"Lancet."},{"key":"S0317167100007009_manual_ref-84","first-page":"1","article-title":"Centers for Disease Control-1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults","volume":"41","year":"1992","journal-title":"MMWR."},{"key":"S0317167100007009_manual_ref-18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/13550280290101094","article-title":"The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy","volume":"8","author":"Sacktor","year":"2002","journal-title":"J Neurovirol."},{"key":"S0317167100007009_manual_ref-5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/13550280290049723","article-title":"Central nervous system infections in individuals with HIV-1 infection","volume":"8","author":"Mamidi","year":"2002","journal-title":"J Neurovirol."},{"key":"S0317167100007009_manual_ref-53","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/13550280600713932","article-title":"Relationship of antiretroviral treatment to postmortem brain tissue viral load in human immunodeficiency virus-infected patients","volume":"12","author":"Langford","year":"2006","journal-title":"J Neurovirol."},{"key":"S0317167100007009_manual_ref-61","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1212\/01.wnl.0000204294.28189.03","article-title":"Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report","volume":"66","author":"Schifitto","year":"2006","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130413"},{"key":"S0317167100007009_manual_ref-6","doi-asserted-by":"publisher","DOI":"10.1007\/s004150050341"},{"key":"S0317167100007009_manual_ref-41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2008.00679.x"},{"key":"S0317167100007009_manual_ref-34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1037\/0278-6133.26.1.40","article-title":"Age-associated predictors of medication adherence in HIV-positive adults: health beliefs, self-efficacy, and neurocognitive status","volume":"26","author":"Barclay","year":"2007","journal-title":"Health Psychol."},{"key":"S0317167100007009_manual_ref-86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1526-4610.1999.3901003.x","article-title":"Primary headaches in HIV-infected patients","volume":"39","author":"Mirsattari","year":"1999","journal-title":"Headache."},{"key":"S0317167100007009_manual_ref-15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.10.1848"},{"key":"S0317167100007009_manual_ref-35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.7326\/0003-4819-121-10-199411150-00008","article-title":"Neurologic manifestations of HIV infection [published erratum appears in Ann Intern Med 1995 Feb 15;122(4):317]","volume":"121","author":"Simpson","year":"1994","journal-title":"Ann Intern Med."},{"key":"S0317167100007009_manual_ref-71","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.20816","article-title":"Sensory neuropathy in human immunodeficiency virus\/acquired immunodeficiency syndrome patients: protease inhibitor-mediated neurotoxicity","volume":"59","author":"Pettersen","year":"2006","journal-title":"Ann Neurol."},{"key":"S0317167100007009_manual_ref-70","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/jnnp.56.4.372","article-title":"Nature and incidence of peripheral nerve syndromes in HIV infection","volume":"56","author":"Fuller","year":"1993","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"S0317167100007009_manual_ref-59","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ana.10729","article-title":"Growth hormone prevents human immunodeficiency virus-induced neuronal p53 expression","volume":"54","author":"Silva","year":"2003","journal-title":"Ann Neurol."},{"key":"S0317167100007009_manual_ref-90","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jns.2005.09.005","article-title":"ALS syndrome in patients with HIV-1 infection","volume":"240","author":"Verma","year":"2006","journal-title":"J Neurol Sci."},{"key":"S0317167100007009_manual_ref-93","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11910-004-0014-8","article-title":"Neuromuscular complications in HIV","volume":"4","author":"Verma","year":"2004","journal-title":"Curr Neurol Neurosci Rep."},{"key":"S0317167100007009_manual_ref-66","first-page":"199","article-title":"Neuropathies in HIV infection","volume":"5","author":"Dalakas","year":"1996","journal-title":"Baillieres Clin Neurol."},{"key":"S0317167100007009_manual_ref-51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11940-004-0023-6","article-title":"HIV Dementia","volume":"6","author":"Nath","year":"2004","journal-title":"Curr Treat Options Neurol."},{"key":"S0317167100007009_manual_ref-78","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1212\/WNL.51.6.1682","article-title":"A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team","volume":"51","author":"Kieburtz","year":"1998","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-80","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1212\/WNL.57.7.1313","article-title":"Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy","volume":"57","author":"Schifitto","year":"2001","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-24","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.7.4643-4649.1994"},{"key":"S0317167100007009_manual_ref-37","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410230712"},{"key":"S0317167100007009_manual_ref-67","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1040832","article-title":"Diseases of the spinal cord in human immunodeficiency virus infection","volume":"19","author":"Di Rocco","year":"1999","journal-title":"Semin Neurol."},{"key":"S0317167100007009_manual_ref-7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1017\/S0317167100003978","article-title":"HIV-related neurological syndromes reduce health-related quality of life","volume":"32","author":"Pandya","year":"2005","journal-title":"Can J Neurol Sci."},{"key":"S0317167100007009_manual_ref-75","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/brain\/awm148","article-title":"Didanosine causes sensory neuropathy in an HIV\/AIDS animal model: impaired mitochondrial and neurotrophic factor gene expression","volume":"130","author":"Zhu","year":"2007","journal-title":"Brain."},{"key":"S0317167100007009_manual_ref-2","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1474-4422(05)70165-4","article-title":"Neurological complications of HIV infection","volume":"4","author":"McArthur","year":"2005","journal-title":"Lancet Neurol."},{"key":"S0317167100007009_manual_ref-42","doi-asserted-by":"publisher","DOI":"10.1097\/00042560-199503010-00008"},{"key":"S0317167100007009_manual_ref-19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.410190602","article-title":"The AIDS dementia complex: I. Clinical features","volume":"19","author":"Navia","year":"1986","journal-title":"Ann Neurol."},{"key":"S0317167100007009_manual_ref-36","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1212\/WNL.42.11.2125","article-title":"Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis","volume":"42","author":"Dal Pan","year":"1992","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2005.07.018"},{"key":"S0317167100007009_manual_ref-21","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120418"},{"key":"S0317167100007009_manual_ref-39","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1016\/S1053-8119(03)00232-5","article-title":"Increased glial metabolites predict increased working memory network activation in HIV brain injury","volume":"19","author":"Ernst","year":"2003","journal-title":"Neuroimage."},{"key":"S0317167100007009_manual_ref-17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13550280590922838","article-title":"Human immunodeficiency virus type 1 genetic diversity in the nervous system: evolutionary epiphenomenon or disease determinant?","volume":"11","author":"van Marle","year":"2005","journal-title":"J Neurovirol."},{"key":"S0317167100007009_manual_ref-81","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00401-005-0983-y","article-title":"Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy","volume":"109","author":"Vendrely","year":"2005","journal-title":"Acta Neuropathol (Berl)."},{"key":"S0317167100007009_manual_ref-27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1212\/WNL.50.3.645","article-title":"A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders [see comments]","volume":"50","year":"1998","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.52.8.1640"},{"key":"S0317167100007009_manual_ref-47","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/158.5.1079"},{"key":"S0317167100007009_manual_ref-3","volume-title":"\u201c3 by 5\u201d Progress Report, December 2004","year":"2004"},{"key":"S0317167100007009_manual_ref-62","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2377-6-42","article-title":"Valproic acid is associated with cognitive decline in HIV-infected individuals: a clinical observational study","volume":"6","author":"Cysique","year":"2006","journal-title":"BMC Neurol."},{"key":"S0317167100007009_manual_ref-26","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1001\/archneur.1997.00550160054016","article-title":"Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group","volume":"54","author":"Ellis","year":"1997","journal-title":"Arch Neurol."},{"key":"S0317167100007009_manual_ref-14","volume-title":"Neuropathology of AIDS","author":"Vinters","year":"1990"},{"key":"S0317167100007009_manual_ref-10","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-48","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1097\/00002030-199909100-00011","article-title":"Neurological outcomes in late HIV infection:adverse impact of neurological survival and protection effect of antiretroviral therapy","volume":"13","author":"Price","year":"1999","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-89","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1097\/01.CCM.0000069516.81522.F4","article-title":"Effect of human immunodeficiency virus on intensive care unit outcome of patients with Guillain-Barre syndrome","volume":"31","author":"Schleicher","year":"2003","journal-title":"Crit Care Med."},{"key":"S0317167100007009_manual_ref-91","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-4-598_1"},{"key":"S0317167100007009_manual_ref-79","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jpainsymman.2007.04.015","article-title":"An open-label pilot study of high-concentration capsaicin patch in painful HIV Neuropathy","volume":"35","author":"Simpson","year":"2008","journal-title":"J Pain Symptom Manage."},{"key":"S0317167100007009_manual_ref-8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0317167100001682","article-title":"The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy","volume":"29","author":"Power","year":"2002","journal-title":"Can J Neuro Sci."},{"key":"S0317167100007009_manual_ref-9","volume-title":"Viral Infections of the nervous system","author":"Johnson","year":"1998"},{"key":"S0317167100007009_manual_ref-25","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200401001-00011"},{"key":"S0317167100007009_manual_ref-52","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","article-title":"Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system","volume":"65","author":"Letendre","year":"2008","journal-title":"Arch Neurol."},{"key":"S0317167100007009_manual_ref-64","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000343854.80344.69"},{"key":"S0317167100007009_manual_ref-69","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-200211080-00002","article-title":"HIV-associated sensory neuropathies","volume":"16","author":"Keswani","year":"2002","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-38","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jmri.20272","article-title":"A multicenter study of two magnetic resonance spectroscopy techniques in individuals with HIV dementia","volume":"21","author":"Sacktor","year":"2005","journal-title":"J Magn Reson Imaging."},{"key":"S0317167100007009_manual_ref-43","first-page":"1367","article-title":"The International HIV Dementia Scale: a new rapid screening test for HIV dementia","volume":"19","author":"Sacktor","year":"2005","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-33","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/00002030-200401001-00004","article-title":"Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse","volume":"18","author":"Hinkin","year":"2004","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-87","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1097\/01.aids.0000192082.41561.49","article-title":"Peripheral neuropathies associated with HIV and hepatitis C co-infection: a review","volume":"19","author":"Estanislao","year":"2005","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02291385","article-title":"Autonomic neuropathy in patients with HIV: course, impact of disease stage, and medication","volume":"10","author":"Gluck","year":"2000","journal-title":"Clin Auton Res."},{"key":"S0317167100007009_manual_ref-65","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00401-004-0852-0","article-title":"Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART","volume":"108","author":"Miller","year":"2004","journal-title":"Acta Neuropathol (Berl)."},{"key":"S0317167100007009_manual_ref-45","first-page":"134","article-title":"Validity of two scales in identifying HIV-associated dementia","volume":"21","author":"Berghuis","year":"1999","journal-title":"J Acquir Immune Defic Syndr."},{"key":"S0317167100007009_manual_ref-94","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09540260701877894","article-title":"Neurocognitive disturbances in HIV","volume":"20","author":"Grant","year":"2008","journal-title":"Int Rev Psychiatry."},{"key":"S0317167100007009_manual_ref-31","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.43.11.2245","article-title":"Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study","volume":"43","author":"McArthur","year":"1993","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/13550280290167948","article-title":"Psychiatric complications in human immunodeficiency virus infection","volume":"8","author":"Koutsilieri","year":"2002","journal-title":"J Neurovirol."},{"key":"S0317167100007009_manual_ref-30","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199401000-00001"},{"key":"S0317167100007009_manual_ref-50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00126334-200204010-00006","article-title":"Therapeutic effects of nonnucleoside reverse transcriptase inhibitors on the central nervous system in HIV-1-infected patients","volume":"29","author":"von Giesen","year":"2002","journal-title":"J Acquir Immune Defic Syndr."},{"key":"S0317167100007009_manual_ref-56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1212\/01.wnl.0000268487.78753.0f","article-title":"A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment","volume":"69","author":"Schifitto","year":"2007","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00005072-199201000-00002","article-title":"Pathology of HIV-1 infection of the central nervous system. A review","volume":"51","author":"Sharer","year":"1992","journal-title":"J Neuropathol Exp Neurol."},{"key":"S0317167100007009_manual_ref-40","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awh269"},{"key":"S0317167100007009_manual_ref-57","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1097\/QAD.0b013e32813384e8","article-title":"Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study","volume":"21","author":"Schifitto","year":"2007","journal-title":"AIDS."},{"key":"S0317167100007009_manual_ref-58","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/nn1127","article-title":"HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neuro-degeneration","volume":"6","author":"Zhang","year":"2003","journal-title":"Nat Neurosci."},{"key":"S0317167100007009_manual_ref-63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1212\/01.wnl.0000227922.22293.93","article-title":"Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patients","volume":"67","author":"Venkataramana","year":"2006","journal-title":"Neurology."},{"key":"S0317167100007009_manual_ref-68","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.seizure.2007.05.017","article-title":"Frequency of seizures and epilepsy in neurological HIV-infected patients","volume":"17","author":"Kellinghaus","year":"2008","journal-title":"Seizure."},{"key":"S0317167100007009_manual_ref-72","doi-asserted-by":"publisher","DOI":"10.1097\/01.wco.0000245366.59446.57"},{"key":"S0317167100007009_manual_ref-73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1529-8027.2001.006001021.x","article-title":"HIV neuropathy: insights in the pathology of HIV peripheral nerve disease","volume":"6","author":"Pardo","year":"2001","journal-title":"J Peripher Nerv Syst."}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100007009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:24:53Z","timestamp":1750461893000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100007009\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["S0317167100007009"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100007009","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}